SCHARF INVESTMENTS, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHARF INVESTMENTS, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$145,226,322
-4.1%
1,425,745
-5.0%
4.34%
-4.5%
Q2 2023$151,474,597
+1.3%
1,501,086
-7.7%
4.54%
-3.8%
Q1 2023$149,600,601
+4.7%
1,625,975
+3.2%
4.72%
+1.1%
Q4 2022$142,904,588
+32.8%
1,575,293
+11.3%
4.67%
+15.2%
Q3 2022$107,601,000
-3.8%
1,415,620
+7.0%
4.06%
+6.4%
Q2 2022$111,799,000
-5.0%
1,322,606
-1.3%
3.82%
+9.3%
Q1 2022$117,662,000
+6.6%
1,340,680
+6.2%
3.49%
+6.6%
Q4 2021$110,405,000
+8.5%
1,262,077
+1.4%
3.27%
+1.9%
Q3 2021$101,794,000
-11.6%
1,244,711
-1.4%
3.21%
-8.1%
Q2 2021$115,199,000
+11.9%
1,262,593
+4.8%
3.50%
-1.9%
Q1 2021$102,977,000
-8.9%
1,204,700
+0.6%
3.56%
-16.3%
Q4 2020$113,083,000
+7.3%
1,197,539
-1.2%
4.26%
-6.2%
Q3 2020$105,426,000
-7.4%
1,212,354
-6.9%
4.54%
-10.9%
Q2 2020$113,792,000
+3.8%
1,302,862
-2.1%
5.10%
-7.1%
Q1 2020$109,673,000
+1.4%
1,330,175
+16.5%
5.48%
+29.6%
Q4 2019$108,119,000
+5.6%
1,141,821
-3.1%
4.23%
+1.2%
Q3 2019$102,363,000
-12.3%
1,177,939
-7.9%
4.18%
-9.2%
Q2 2019$116,745,000
+39.1%
1,278,557
+46.4%
4.60%
+42.2%
Q1 2019$83,941,000
+9.3%
873,108
-2.4%
3.24%
+6.1%
Q4 2018$76,800,000
+10.3%
895,002
+10.8%
3.05%
+25.8%
Q3 2018$69,620,000
+19.2%
808,030
+4.5%
2.42%
+16.1%
Q2 2018$58,429,000
-9.7%
773,322
-3.3%
2.09%
+15.0%
Q1 2018$64,678,000
-13.2%
799,982
-9.9%
1.82%
+7.4%
Q4 2017$74,528,000
-7.6%
887,665
-5.5%
1.69%
-13.5%
Q3 2017$80,660,000
+0.4%
939,552
-2.4%
1.96%
+3.7%
Q2 2017$80,368,000
+9.2%
962,827
-2.9%
1.89%
+7.2%
Q1 2017$73,611,000
-2.3%
991,123
-4.2%
1.76%
+0.7%
Q4 2016$75,359,000
-12.2%
1,034,587
-4.8%
1.75%
-12.3%
Q3 2016$85,833,000
-3.0%
1,087,041
+1.4%
1.99%
+0.3%
Q2 2016$88,480,000
+17.6%
1,072,354
+3.2%
1.99%
+13.5%
Q1 2016$75,262,000
-13.1%
1,038,950
+3.3%
1.75%
-15.2%
Q4 2015$86,559,000
-41.2%
1,006,035
-37.2%
2.06%
-46.6%
Q3 2015$147,232,000
-9.4%
1,601,739
-3.1%
3.86%
-7.3%
Q2 2015$162,482,000
+4.0%
1,652,250
+4.3%
4.17%
-3.8%
Q1 2015$156,226,000
+14.2%
1,584,279
+7.4%
4.33%
+5.4%
Q4 2014$136,745,000
+7.8%
1,475,768
+9.5%
4.11%
-8.4%
Q3 2014$126,817,000
+10.1%
1,347,256
+5.9%
4.48%
+0.2%
Q2 2014$115,181,000
+8.5%
1,272,297
+1.9%
4.47%
-5.2%
Q1 2014$106,201,000
+11.4%
1,249,132
+5.3%
4.72%
+10.7%
Q4 2013$95,327,000
+0.5%
1,185,951
-4.1%
4.26%
-4.8%
Q3 2013$94,824,000
+11.8%
1,236,132
+3.0%
4.48%
-2.6%
Q2 2013$84,852,0001,199,9964.60%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders